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Abstract CD38 is a multifunctional cell surface ectoenzyme
that catalyzes both the synthesis of cyclic ADP-ribose from
NAD+ and its hydrolysis to ADP-ribose. In this work, we
investigated the metabolism of NADP+ by CD38 expressed on
human platelets. Incubation of either platelet membranes or
intact cells with NADP+ resulted in the rapid and time-dependent
accumulation of ADP-ribose 2P-phosphate that paralleled the
consumption of the substrate. However, under the same
conditions, synthesis of cyclic ADP-ribose 2P-phosphate was
not observed. By immunoprecipitation experiments, we identified
CD38 as the enzyme responsible for the observed NADP+
glycohydrolase activity. The lack of detection of cyclic ADP-
ribose 2P-phosphate was not due to its rapid hydrolysis, since
direct incubation of platelet membranes with cyclic ADP-ribose
2P-phosphate did not result in the formation of ADP-ribose 2P-
phosphate. By contrast, the same membrane samples expressed a
significant ability to hydrolyze cyclic ADP-ribose to ADP-
ribose. The absence of cyclic ADP-ribose 2P-phosphate hydrolase
activity was also confirmed using high concentrations of
substrate and by analysing both intact Jurkat T-lymphocytes
and immunoprecipitated CD38. These results indicate that
CD38, which is a multifunctional enzyme towards NAD+,
displays exclusively a NADP+ glycohydrolase activity and is
unable to catalyze both the synthesis and the hydrolysis of cyclic
ADP-ribose 2P-phosphate.
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1. Introduction
Human CD38 is a type II transmembrane glycoprotein in-
volved in several cellular functions, including activation, dif-
ferentiation and adhesion [1]. Based on the high sequence
homology with the ADP-ribosyl cyclase from Aplysia californ-
ica, an enzyme that converts NAD into cyclic ADP-ribose
(cADPR) [2], an enzymatic function for CD38 has been pro-
posed. Indeed, it has been demonstrated that CD38 is actually
a multifunctional enzyme [3]. Its extracellular domain pos-
sesses both ADP-ribosyl cyclase activity, is able to synthesize
cADPR from NAD and cADPR hydrolase activity is able to
hydrolyze cADPR to ADP-ribose (ADPR). Thus, CD38 may
be responsible for the transient formation of cADPR, which is
a potent stimulator of Ca2 release from speci¢c intracellular
stores [4]. The sum of these reactions results in a NAD
glycohydrolase activity causing the conversion of NAD to
ADPR. However, it has recently been demonstrated that for-
mation of cADPR from NAD is an alternative reaction,
rather than an obligatory step in the NAD glycohydrolase
activity of NAD [5,6].
In addition to NAD, human CD38, as well as the ADP-
ribosyl cyclase from A. californica, can utilize NADP as
substrate [7]. It has been demonstrated that, at acidic pH
and in the presence of nicotinic acid, both enzymes catalyze
the exchange of the nicotinamide group of NADP with nic-
otinic acid to produce nicotinic acid adenine dinucleotide
phosphate (NAADP) [7]. This compound acts as an intra-
cellular messenger able to promote Ca2 release from intra-
cellular stores distinct from those sensitive to either inositol
1,4,5-trisphosphate (IP3) or cADPR [8,9]. Much less is known
about the NADP metabolism by CD38 at physiological pH.
Aarhus and coworkers reported that, in these conditions, the
ADP-ribosyl cyclase from A. californica converts NADP to
cyclic ADP-ribose 2P-phosphate (2P-P-cADPR), while CD38
causes hydrolysis of NADP to ADP-ribose 2P-phosphate
(2P-P-ADPR) [7]. However, the expression of a 2P-P-ADP-ri-
bosyl cyclase and 2P-P-cADPR hydrolase activity by CD38
was not investigated.
We have previously reported that enzymatically active
CD38 is expressed on the plasma membrane of human plate-
lets and translocates to the cytoskeleton upon platelet stimu-
lation with thrombin [10,11]. Mobilization of Ca2 from intra-
cellular stores plays a key role in the biochemical mechanisms
of platelet activation induced by a variety of extracellular
agonists [12]. This process is known to be promoted by IP3,
produced through the agonist-induced activation of phospho-
lipase C [12]. By contrast, cADPR does not seem to play any
role as Ca2-releasing agent in these cells [13,14]. However,
the possibility that some metabolites from NADP produced
by CD38 may be involved in Ca2 mobilization in platelets
cannot be ruled out. NAADP, which is a potent Ca2-mo-
bilizing agent, is produced by CD38 through a base exchange
reaction at acidic pH and in the presence of high concentra-
tions of nicotinic acid [7^9] and thus, it is unlikely to play a
physiological role in platelet activation. By contrast, a role for
2P-P-cADPR, produced by the ADP-ribosyl cyclase from A.
californica at neutral pH on Ca2 release, has been proposed
[15].
The aim of this work was to investigate the metabolism of
NADP by platelet CD38 at physiological pH, in order to get
more insights into the enzymatic activities of this glycoprotein
and in search for new messengers regulating Ca2 mobiliza-
tion in platelets. The results demonstrate that CD38 causes
hydrolysis of NADP to 2P-P-ADPR, but not synthesis of 2P-
P-cADPR. Moreover, we found that 2P-P-cADPR, unlike
cADPR, was not a substrate for CD38. These results demon-
strate that the expression of the NADP glycohydrolase ac-
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tivity does not require synthesis and degradation of 2P-P-
cADPR from NADP and argue against a role of 2P-P-
cADPR in platelet activation.
2. Materials and methods
2.1. Materials
NADP, 2P-P-ADPR, 2P-P-cADPR, cADPR were purchased from
Sigma. Microcon 3 ¢lters were from Amicon. Sepharose CL-2B and
protein A-Sepharose were from Amersham Pharmacia Biotech. Yur-
kat T-cells and the monoclonal antibody IB4 against CD38 were a gift
from Prof. F. Malavasi (Department of Genetics, Biology and Med-
ical Chemistry, University of Turin, Turin, Italy). All other reagents
were of analytical grade.
2.2. Platelets and Jurkat T-lymphocytes preparation
Blood was taken from healthy volunteers using citric acid-citrate-
dextrose as anti-coagulant. Platelets were prepared by gel-¢ltration on
a Sepharose CL-2B column, equilibrated with HEPES bu¡er (10 mM
HEPES, 137 mM NaCl, 2.9 mM KCl, 12 mM NaHCO3, pH 7.4) as
previously described [16]. The platelet count was ¢nally adjusted to
109 cells/ml. Jurkat T-lymphocytes were cultured in RPMI 1640 sup-
plemented with 10% fetal bovine serum, 2 mM glutamine, 100 U/ml
penicillin and 100 U/ml streptomycin at 37‡C in a humidi¢ed atmos-
phere with 5% CO2. Cells were collected by centrifugation, washed
twice with HEPES bu¡er and ¢nally resuspended at a concentration
of 107 cells/ml.
2.3. Membrane preparation
Platelets were prepared from concentrates obtained from the local
blood bank (Servizio di Immunoematologia e Transfusione, IRCCS
Policlinico S. Matteo, Pavia, Italy) as described [10] and ¢nally re-
suspended at a ¢nal count of 2U109 cells/ml in hypotonic bu¡er (10
mM HEPES, pH 7.5, 100 WM PMSF, 10 Wg/ml leupeptin, 10 Wg/ml
aprotinin). Platelets were disrupted by sonication and then centri-
fuged at 1800Ug for 20 min to eliminate intact cells. The supernatant
was ultracentrifuged at 100 000Ug for 45 min and the membrane
pellet was washed once with hypotonic bu¡er. The membranes were
¢nally resuspended in HEPES bu¡er, the protein concentration was
determined with the bicinchoninic acid assay and adjusted at 3^7 mg
of membrane proteins/ml. Membranes were stored at 370‡C until
used.
2.4. Immunoprecipitation
Platelet membrane samples (typically 250 Wl containing 0.4 mg of
membrane proteins) were lysed by addition of an equal volume of ice-
cold immunoprecipitation bu¡er (HEPES bu¡er containing 2% Non-
idet P40, 0.5% sodium deoxycholate, 1 mM PMSF, 10 Wg/ml leupep-
tin, 10 Wg/ml aprotinin). Upon incubation on ice for 15 min, lysates
were centrifuged at 13 000Ug for 5 min. The cleared supernatants
were incubated with 4 Wg of the anti-CD38 monoclonal antibody
IB4 or with 4 Wg of unrelated mouse immunoglobulins for 2 h at
4‡C. Protein A-Sepharose (100 Wl of a 50 mg/ml stock solution) was
then added and samples were incubated at 4‡C for 30 min. The
protein A-Sepharose pellets were collected by brief centrifugation,
washed twice with ice-cold immunoprecipitation bu¡er and ¢nally
resuspended with 100 Wl of HEPES bu¡er for enzymatic determina-
tions.
2.5. Enzymatic analysis
Measurements of enzymatic activities of CD38 were performed on
100 Wl samples containing 50 Wg membrane proteins, 108 intact plate-
lets, 107 Jurkat T-cells or immunoprecipitates. Samples were pre-
warmed at 37‡C and reactions were started by addition of the nucleo-
tide substrate (typically, 100 WM NADP, 100 WM 2P-P-cADPR or
100 WM cADPR). Immediately after addition of the substrates or after
incubation at 37‡C for the time indicated in the ¢gure legends, sam-
ples were centrifuged at 13 000Ug for 5 min. The supernatants were
ultra¢ltered on Microcon 3 membranes (cut-o¡ 3000 D) and then
analyzed by reverse-phase HPLC using a 25U0.46 cm Supelcosil
LC-18T column as described [10]. The amount of nucleotides was
determined using a calibration curve obtained by analyzing a known
amount of standard nucleotides.
3. Results and discussion
Analysis by reverse-phase HPLC of the nucleotides pro-
duced upon incubation of platelet membranes with 100 WM
NADP revealed a progressive decrease of the substrate con-
centration, which was paralleled by a time-dependent increase
of a new nucleotide that co-migrated with authentic 2P-P-
ADPR (Fig. 1A). In these experiments, we also investigated
the possible production of 2P-P-cADPR upon incubation of
platelet membranes with NADP. Under the chromato-
graphic conditions used, 2P-P-cADPR eluted at about 1.9
min, well separated from 2P-P-ADPR which was eluted at
2.9 min (data not shown). However, as shown in Fig. 1A,
production of 2P-P-cADPR was never observed, even after 2
h incubation of platelet membranes with NADP. Therefore,
Fig. 1. Metabolism of NADP by platelet membranes and intact
cells. (A) Platelet membrane preparations. (B) Intact gel-¢ltered
platelets were incubated with 100 WM NADP at 37‡C. At increas-
ing time points, samples were centrifuged and ultra¢ltered on Mi-
crocon 3 membranes. 20 Wl aliquots were then subjected to reverse-
phase HPLC analysis. NADP, 2P-P-ADPR and 2P-P-cADPR were
identi¢ed by co-elution with standard nucleotides and quantitated
using a calibration curve obtained with known amounts of each nu-
cleotide analyzed. Results are the mean þ S.D. of four di¡erent ex-
periments.
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platelet membranes are able to hydrolyze NADP to 2P-P-
ADPR without a detectable production of 2P-P-cADPR. We
next analyzed whether the NADP glycohydrolase activity
detected in platelet membranes was due to an ectoenzyme.
Upon incubation of intact human platelets with NADP,
we observed a time-dependent accumulation of 2P-P-ADPR
similar to that produced by membrane preparations (Fig.
1B). Moreover, also in this case, synthesis of 2P-P-cADPR
was not observed (Fig. 1B). To demonstrate that the ectoen-
zyme responsible for the hydrolysis of NADP to 2P-P-ADPR
was the CD38 molecule, platelet membranes were solubilized
and immunoprecipitated with the anti-CD38 monoclonal anti-
body IB4 or with unrelated immunoglobulins as control. The
immunoprecipitates were mixed with 100 WM NADP and the
concentrations of NADP, 2P-P-cADPR and 2P-P-ADPR
were measured by HPLC analysis immediately upon addition
of the substrate and after incubation at 37‡C for 60 min. Fig.
2 shows that CD38 immunoprecipitated with the IB4 mono-
clonal antibody was able to convert NADP to 2P-P-ADPR
without accumulation of 2P-P-cADPR. Very little enzymatic
activity was detected when immunoprecipitates obtained with
unrelated immunoglobulins were tested and could be due to
the aspeci¢c precipitation of a small amount of CD38 mole-
cules (Fig. 2).
These results, that indicate that platelet CD38 catalyzes the
hydrolysis of NADP to 2P-P-ADPR without apparent gen-
eration of 2P-P-cADPR, are consistent with previously re-
ported data, showing that the only nucleotide detectable
upon incubation of puri¢ed CD38 with NADP at physiolog-
ical pH is 2P-P-ADPR [7]. On the other hand, we have pre-
viously shown that, when tested with NAD as substrate,
platelet CD38 produces a small amount of cADPR in addi-
tion to ADPR [10]. Therefore, our data suggest that NAD
Fig. 2. Hydrolysis of NADP by immunoprecipitated CD38. Platelet membranes were solubilized with immunoprecipitation bu¡er and incu-
bated with the anti-CD38 monoclonal antibody IB4 or with unrelated mouse immunoglobulins (IgG) as control. Immunoprecipitates were incu-
bated at 37‡C with 100 WM NADP. The amounts of NADP, 2P-P-cADPR and 2P-P-ADPR were determined immediately after the addition
of the substrate (t = 0) and after incubation for 60 min. Results are expressed as nmol of nucleotides produced by immunoprecipitated materials
obtained from 1 mg of solubilized membrane proteins and are the mean þ S.D. of three separated experiments.
Fig. 3. 2P-P-cADPR and cAPRP hydrolase activity in platelet mem-
branes. Platelet membranes (100 Wl, 50 Wg of proteins) were incu-
bated at 37‡C with 100 WM cADPR or 100 WM 2P-P-cADPR for in-
creasing times. The production of ADPR and 2P-P-ADPR was
evaluated by HPLC analysis. Results are the mean þ S.D. of three
separated experiments.
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and NADP are both substrates for CD38, but are di¡erently
metabolized. Moreover, when NAD is the substrate, CD38
behaves like a multifunctional enzyme and the synthesized
cADPR is rapidly hydrolyzed to ADPR [3]. Therefore, it is
possible that the lack of detection of 2P-P-cADPR upon in-
cubation of platelet CD38 with NADP re£ects its rapid hy-
drolysis to 2P-P-ADPR through a 2P-P-cADPR hydrolase ac-
tivity. A similar enzymatic activity was reported to be
expressed by a NAD(P) glycohydrolase from canine spleen
[15]. Therefore, we incubated platelet membranes with 2P-P-
cADPR as substrate and the production of 2P-P-ADPR was
evaluated by HPLC analysis. As shown in Fig. 3, formation
of 2P-P-ADPR was not observed after up to 2 h incubation.
By contrast, incubation of the same platelet membrane prep-
arations with cADPR resulted in a rapid and time-dependent
synthesis of ADPR (Fig. 3). Therefore, platelet CD38, which
displays cADPR hydrolase activity, does not hydrolyze 2P-P-
cADPR to 2P-P-ADPR.
The only enzyme described to possess 2P-P-cADPR hydro-
lase activity is a canine spleen NAD(P) glycohydrolase [15].
In this case, however, the Km for 2P-P-cADPR was calculated
to be about 140 WM. Since our enzymatic determinations were
performed using 100 WM of substrate, we could not rule out
the possibility that these conditions were not appropriate to
detect 2P-P-cADPR hydrolase activity of CD38. Therefore, we
performed new experiments in which platelet membranes, as
well as CD38 immunoprecipitated with the IB4 monoclonal
antibody were incubated with 1 mM 2P-P-cADPR or 1 mM
cADPR. Fig. 4 shows that even when high concentrations of
substrate were used, production of 2P-P-ADPR was not ob-
served. Under the same conditions, production of ADPR
from cADPR was evident. Finally, the 2P-P-cADPR hydrolase
activity of CD38 was also tested using Jurkat T-cells instead
of platelets, since these cells express a higher number of CD38
molecules than platelets. As shown in Fig. 4, Jurkat T-cells,
that signi¢cantly hydrolyzed cADPR to ADPR, failed to syn-
thesize 2P-P-ADPR when incubated with 1 mM 2P-P-cADPR
(Fig. 4). These results clearly indicate that CD38 does not
express 2P-P-cADPR hydrolase activity.
In conclusion, our results demonstrate that CD38, which is
a multifunctional enzyme towards NAD, expressing ADP-
ribosyl cyclase, cADPR hydrolase and NAD glycohydrolase
activities, is able to metabolize NADP exclusively through a
NADP glycohydrolase activity. Based on the multifunction-
ality of CD38, the NAD glycohydrolase activity has been
considered to represent the sum of the ADP-ribosyl cyclase
and cADPR hydrolase activities [3,17,18]. However, this mod-
el has recently been hampered by accurate kinetic measure-
ments of the enzymatic reaction mechanism, leading to the
conclusion that the synthesis of cADPR from NAD is alter-
native to the production of ADPR and that cADPR is not an
obligatory intermediate during the NAD glycohydrolase ac-
tivity [5,6]. The results presented in this work, demonstrating
the production of 2P-P-ADPR from NADP by CD38 in the
absence of synthesis and hydrolysis of 2P-P-cADPR, provide
further evidence supporting this model.
cADPR and 2P-P-cADPR di¡er exclusively for the phos-
phate group in the 2P-position of the ribose moiety. It is
thus surprising that while cADPR is a substrate for CD38,
2P-P-cADPR is not. This may re£ect the inability of 2P-P-
cADPR to interact with the active site of CD38 due to the
phosphate group. It is therefore possible that upon binding of
NADP and cleavage of the nicotinamide-ribose bond, a con-
formational change of the CD38 molecule occurs to produce
an enzyme 2P-P-ADPR intermediate that necessarily proceeds
toward the release of 2P-P-ADPR. However, in the absence of
structural data on the three dimensional conformation of
CD38 in association with the di¡erent nucleotides, this possi-
bility remains exclusively speculative.
The ability of 2P-P-cADPR to act directly as a Ca2-mobi-
lizing agent is still controversial [7,15]. In any case, our results
showing that 2P-P-cADPR is not produced in intact platelets
by CD38 (or by other still unidenti¢ed enzymes) indicate that
it is unlikely for this molecule to play a role in the regulation
of Ca2 mobilization in platelets. Considering that these cells
are not sensitive to cADPR either [13,14], the physiological
role of CD38 in platelets does not seem to be related to the
control of Ca2 mobilization.
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